Skip to main content
TLRY
NASDAQ Life Sciences

Tilray Brands Reports Record Q3 Revenue and Gross Profit, Significantly Reduces Net Loss

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
8
Price
$6.68
Mkt Cap
$753.8M
52W Low
$3.507
52W High
$23.2
Market data snapshot near publication time

summarizeSummary

Tilray Brands reported record Q3 fiscal 2026 net revenue and gross profit, with a substantial 97% reduction in net loss, and reconfirmed its full-year adjusted EBITDA guidance.


check_boxKey Events

  • Record Q3 Financial Performance

    Net revenue increased 11% year-over-year to a record $206.7 million, and gross profit rose 6% to a record $55.0 million.

  • Significant Net Loss Reduction

    Net loss improved by 97% to $25.2 million, a substantial reduction from $793.5 million in the prior year period, with net loss per share improving to $(0.24) from $(8.69).

  • Adjusted EBITDA Growth

    Adjusted EBITDA increased 19% to $10.7 million, reflecting improved operational efficiency.

  • Strong International Cannabis Growth

    International cannabis net revenue accelerated with 73% year-over-year growth, and Canadian adult-use and medical cannabis net revenue combined increased 8%.


auto_awesomeAnalysis

Tilray Brands delivered strong third-quarter fiscal 2026 results, showcasing record net revenue and gross profit, alongside a dramatic 97% reduction in net loss. This significant improvement in profitability, moving from a $793.5 million net loss to $25.2 million, indicates a positive shift in the company's financial health. The robust growth in international cannabis revenue and the reconfirmation of fiscal year 2026 adjusted EBITDA guidance provide further confidence in the company's operational execution and strategic direction. The recent BrewDog acquisition and Carlsberg partnership position Tilray for expanded global reach in the craft beverage market, complementing its core cannabis business.

At the time of this filing, TLRY was trading at $6.68 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $753.8M. The 52-week trading range was $3.51 to $23.20. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed TLRY - Latest Insights

TLRY
Apr 23, 2026, 8:30 AM EDT
Source: Reuters
Importance Score:
9
TLRY
Apr 22, 2026, 12:46 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
TLRY
Apr 15, 2026, 8:54 AM EDT
Filing Type: 8-K
Importance Score:
8
TLRY
Apr 15, 2026, 7:43 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
TLRY
Apr 14, 2026, 6:27 PM EDT
Filing Type: 8-K
Importance Score:
7
TLRY
Apr 02, 2026, 4:05 PM EDT
Source: Wiseek News
Importance Score:
8
TLRY
Apr 01, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
8
TLRY
Apr 01, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
TLRY
Mar 16, 2026, 7:33 AM EDT
Source: Reuters
Importance Score:
8
TLRY
Mar 12, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8